Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colm Morrissey

Showing results (101-110 of 172) with videos related to

Pageof 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2026
Molecular Characterization of KLK2 RNA Expression in Prostate CancerRana R McKay, Shayan S Nazari, Andrew Elliott, et al.
Neoplasia (New York, N.Y.)|May 14, 2020
Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4Daniel J Coleman, David A Sampson, Archana Sehrawat, et al.
Nature Communications|November 11, 2022
Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunityDeyong Jia, Zhicheng Zhou, Oh-Joon Kwon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 26, 2013
Prostate cancer cell phenotypes based on AGR2 and CD10 expressionMelissa E Ho, Sue-Ing Quek, Lawrence D True, et al.
The Prostate|October 5, 2023
Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
NAR Cancer|August 28, 2023
Co-evolution of <i>AR</i> gene copy number and structural complexity in endocrine therapy resistant prostate cancerAndrej Zivanovic, Jeffrey T Miller, Sarah A Munro, et al.
The American Journal of Pathology|June 28, 2011
Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinasesAaron P Putzke, Aviva P Ventura, Alexander M Bailey, et al.
Nature Genetics|April 26, 2022
HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancerXiaodong Lu, Ka-Wing Fong, Galina Gritsina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2019
Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate CancerAlexandra N Corella, Ma Victoria Andrea Cabiliza Ordonio, Ilsa Coleman, et al.
Cancer Research|May 17, 2020
Correction: Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate CancerShangze Li, Ka-Wing Fong, Galina Gritsina, et al.
Pageof 18

Showing results (101-110 of 172) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2026
Molecular Characterization of KLK2 RNA Expression in Prostate CancerRana R McKay, Shayan S Nazari, Andrew Elliott, et al.
Neoplasia (New York, N.Y.)|May 14, 2020
Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4Daniel J Coleman, David A Sampson, Archana Sehrawat, et al.
Nature Communications|November 11, 2022
Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunityDeyong Jia, Zhicheng Zhou, Oh-Joon Kwon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 26, 2013
Prostate cancer cell phenotypes based on AGR2 and CD10 expressionMelissa E Ho, Sue-Ing Quek, Lawrence D True, et al.
The Prostate|October 5, 2023
Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
NAR Cancer|August 28, 2023
Co-evolution of <i>AR</i> gene copy number and structural complexity in endocrine therapy resistant prostate cancerAndrej Zivanovic, Jeffrey T Miller, Sarah A Munro, et al.
The American Journal of Pathology|June 28, 2011
Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinasesAaron P Putzke, Aviva P Ventura, Alexander M Bailey, et al.
Nature Genetics|April 26, 2022
HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancerXiaodong Lu, Ka-Wing Fong, Galina Gritsina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2019
Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate CancerAlexandra N Corella, Ma Victoria Andrea Cabiliza Ordonio, Ilsa Coleman, et al.
Cancer Research|May 17, 2020
Correction: Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate CancerShangze Li, Ka-Wing Fong, Galina Gritsina, et al.
Pageof 18